Walker on Progress

With its second global plant in Thailand, NatureWorks doubles down on Asia, challenging the plastics industry and testing the limits of a green economy.

U.S. fintech Mbanq bypasses VCs, tapping European debt markets with a Swiss bank's backing to fuel its global Earned Wage Access platform.

A new bill backed by police aims to turn the tide on senior scams by funding specialized task forces. But is this strategic shift enough to halt the crisis?

Desjardins Investments is merging and terminating multiple mutual funds. We dissect the strategy, the impact on investors, and a curious move in ESG.

Tayeh Capital's majority stake in Council Advisors isn't just another transaction; it's a strategic blueprint for private equity's growing ambition in consulting.

Bio-Thera Solutions has begun a Phase 1 trial for BAT8013, a novel ADC targeting CD25 to deplete immunosuppressive cells in the tumor microenvironment.

Teladoc One promises a new era of connected care with an AI-driven model and a risky payment structure. Is it the future or a high-stakes gamble?

After a disastrous Q2 report and lowered guidance, all eyes are on Azenta's August 5th call. We dissect the key metrics and strategic shifts to watch.

A new survey reveals a major shift in consumer expectations, with 58% of Americans demanding two-factor authentication for their most sensitive files.

With UK approval for its FLAMINGO-01 trial, Greenwich LifeSciences partners with a top cancer center, signaling a key move in the race to prevent breast cancer recurrence.

A&G Real Estate Partners' appointment of Andrew Jacobs isn't just a new hire. It's a strategic move to master a bifurcated market. Here's why.

The popular contest's move to an app-only format reveals a sophisticated strategy to capture customer data, drive digital loyalty, and outmaneuver rivals.

A 55,000 sq ft facility in Texas is more than new real estate. It’s Qarbon Aerospace's high-stakes entry into the elite world of classified defense manufacturing.

Growth equity firm Summit Partners' latest hire signals a major shift. It's no longer enough to fund innovation; firms must now build it from within.

Oppenheimer's major talent acquisition from Guggenheim isn't just about expansion; it's a strategic pivot towards deep client partnership in a complex market.

Kibow Biotech's AANP award for its kidney health probiotics isn't just a win for the company; it's a major nod to the growing role of the gut-kidney axis.

New FDA and EU regulations are forcing a supply chain overhaul. Portugal's Altinteg is betting its 'as-a-service' model can turn this compliance burden into a strategic edge.

An institutional investor’s decisive move spotlights a €205M valuation gap in the Addiko Bank takeover, raising critical questions about M&A fairness.

As IDACORP readies its Q2 report, all eyes are on how its hydropower strategy is fueling growth and navigating risks in one of America's fastest-growing regions.

Drake Software's new Audit Defense is more than a feature. It’s a strategic play to own the entire tax professional workflow, from intake to IRS notice.